The largest database of trusted experimental protocols

4 protocols using kyse520

1

Esophageal Squamous Cell Carcinoma Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six kinds of ESCC cells (SHEE, KYSE180, TE8, KYSE150, KYSE410 and KYSE520) were purchased from ATCC and cultured in RPMI 1640 medium with 10% fetal bovine serum and 1% antibiotics at 37 °C in 5% CO2.
+ Open protocol
+ Expand
2

Cell Line and PDX Authentication Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
NCI-H3122, HT29, MIAPaCa-2, and NCI-H1975 cells were obtained from ATCC, KYSE-520 from DSMZ, RT 112/84 from ECACC, and EBC-1 from JCRB. All cell lines were authenticated by STR profiling, and regularly evaluated for Mycoplasma (MycoAlert, Lonza, Inc.). CR5087 PDX was obtained from Crown Biosciences. MGH915–4Y10 PDX was provided by Dr. Aaron Hata, MGH Cancer Center. Lorla-06 (EML4-ALK) fusion-positive NSCLC cell lines were derived from parental NCI-H3122 cells by long-term in vitro culture in the presence of lorlatinib. See Supplementary Methods for additional molecular validation of cell lines and PDXs.
+ Open protocol
+ Expand
3

Cell Line Generation and Maintenance

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the parental cell lines used in this study (MDA-MB-468 [RRID:CVCL_0419], KYSE520 [RRID:CVCL_1355], U2OS [RRID:CVCL_0042], Jurkat [RRID:CVCL_0367], and NCI-H1975 [RRID:CVCL_UE30]) were purchased from ATCC. The SHP2 knockout U2OS cell line was created previously (LaRochelle et al., 2018 (link)). To generate rescued SHP2-null U2OS lines, knockout cells were infected with retrovirus harboring the wild-type or mutant SHP2 cDNAs and FACS sorted for GFP-positive cells. MDA-MB-468 parental cells stably expressing full-length GAB1-GFP, GAB2-GFP, SHP2, PTP, and N-SH2-C-SH2 cDNAs were also generated similarly. U2OS cell lines were grown in McCoy’s 5A media with 10% fetal bovine serum (FBS). MDA-MB-468 cells were cultured in Leibovitz’s L-15 media with 10% FBS without CO2. All other cell lines (KYSE520, Jurkat, and NCI-H1975) were maintained in RPMI-1640 supplemented with 10% FBS at 5% CO2. Cell lines were acquired from sources provided in the key resources table. All cell lines used in this study tested negative for mycoplasma contamination.
+ Open protocol
+ Expand
4

Development of ADM-Resistant Esophageal Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ESCC cell lines, including CaEs-17, TE-1, Eca109, KYSE520, KYSE30, EC9706, and TE-10 were obtained from ATCC. The normal esophageal epithelial cell lines, including HEEC and Het-1A were obtained from Suran biotechnology Co., Ltd (Shanghai, China). All cells were maintained in Dulbecco's Modi ed Eagle Medium supplemented with 10 % fetal bovine serum and 10 % penicillin-streptomycin at 37 °C in a humidi ed incubator containing 5% CO 2 .
Establishment of ADM-resistant cells ADM-resistant cells Eca109/ADM and EC9706/ADM were incubated from parental Eca109 and EC9706 cells under continuous exposure to ADM with gradually increasing concentrations of docetaxel from 5 nM to 200 nM in the culture medium. Brie y, Eca109 and EC9706 cells were incubated rst with 5 nM ADM for 2 days followed by incubation in the absence of ADM until the ADM-sensitive clones died. Then, survivable cells were cultured in the presence of 10 nM Dox. The same procedure was repeated until cells that were viable at 200 nM ADM were obtained. The surviving cells repopulated and after 10 months, the cells dividing freely in 10 nM and 200 nM ADM-containing media were considered as resistant cell lines and labeled as "Eca109/ADM" and "EC9706/ADM," respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!